Domestic Participation in 42nd JP Morgan Healthcare Conference: Focus on Korean Pharma/Bio Companies
[앵커] This year’s JP Morgan Healthcare Conference was attended by approximately 600 companies and 8,000 corporate investors. In particular, as a meeting can only be held with an official invitation from JP Morgan, the situation being discussed with the participating companies attracts attention. Which domestic companies participated? Correspondent Hyosun Kim reports from the JP Morgan […]
